ArticleSaudi medical journal2026
Targeted Neonatal Echocardiography and Neonatal Hemodynamics in the Kingdom of Saudi Arabia:
Article in Saudi medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the impact of a newly established targeted neonatal echocardiography (TNE) and Neonatal Hemodynamics consultation service on the assessment and management of neonates.
methodsThis is a descriptive retrospective cohort study that included all neonates who underwent TNE consultations in the Neonatal Intensive Care Unit from October 2023 and September 2024. Clinical indications, diagnostic findings, and subsequent management were analyzed.
resultA total of 237 TNE consultations were performed for 105 neonates. The mean gestational age was 29.9 weeks, and the mean birth weight was 1433 grams. On average, 19.8 echocardiographic scans were performed per month. The leading indications for consultation were assessment of patent ductus arteriosus (PDA) (43%), acute pulmonary hypertension (16.4%), screening for chronic pulmonary hypertension (18.6%), neonatal hypotension (17.7%), heart function (0.8%), and central line assessment (3.4%). Among the cohort, 83 neonates (79%) received targeted interventions based on TNE findings. Of these, 38 neonates (36.2%) born at <30 weeks' gestation were treated with pharmacologic agents for PDA closure. Twenty-three neonates (22%) received inhaled nitric oxide and inotropes for acute pulmonary hypertension, while 22 neonates (21%) received inotropes or vasopressors for neonatal hypotension.
conclusionThe implementation of a dedicated TNE consultation service was associated with high utilization and had a measurable impact on clinical decision-making. While PDA assessment remained the most common indication, a substantial proportion of consultations supported management in cases of pulmonary hypertension and hypotension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.